References
- 1. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019—COVID-19. Clinical Microbiology Reviews. 2020;33: e00028–e00020.10.1128/CMR.00028-20
- 2. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, Mcginn T, Davidson KW. Presenting characteristics, comorbidities and outcomes among 5,700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323: 2052–2059.10.1001/jama.2020.6775
- 3. Huang C, Wang Y, Li X, Ren Li, Zhao J, Hu Yi, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223): 497–506.10.1016/S0140-6736(20)30183-5
- 4. Ministry of Health & Family Welfare, Government of India. Revised guidelines on clinical management of COVID-19. Available from: https://www.mohfw.gov.in/pdf/RevisedNational-ClinicalManagementGuidelineforCOVID1931032020.pdf [Accessed 20th June 2020].
- 5. World Health Organization. Clinical management of COVID-19. Available from: https://www.who.int/publicationsdetail-redirect/clinical-anagement-of-covid-19 [Accessed 22nd November 2020].
- 6. Varghese GM, John R, Manesh A, Karthik R, Abraham OC. Clinical management of COVID-19. Indian Journal of Medical Research. 2020;151(5): 401–410.10.4103/ijmr.IJMR_957_20753043532611911
- 7. Indian Council of Medical Research. Available from: https://main.icmr.nic.in/content/covid-19 [Accessed 22nd November 2020].
- 8. Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The New England Journal of Medicine. 2000;342: 1301–1308.10.1056/NEJM20000504342180110793162
- 9. Gupta N, Agrawal S, Ish P, Mishra S, Gaind R, Usha G, et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Archives for Chest Disease. 2020;90: 1294.10.4081/monaldi.2020.129432290644
- 10. Pande D, Kochhar A, Saini S, Ganapathy U, Gogia AR. An update on initial epidemiological profile, clinical course, and outcome of COVID-19 patients at a tertiary care center in India. Indian Journal of Palliative Care. 2020;26(Suppl S1): 36–39.10.4103/IJPC.IJPC_146_20753498233088084
- 11. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11): 1061–1069.10.1001/jama.2020.1585704288132031570
- 12. Budhiraja S, Soni A, Jha V, Indrayan A, Dewan A, Singh O, et al. Clinical profile of first 1000 COVID-19 cases admitted at tertiary care hospitals and the correlates of their mortality: an Indian experience. medRxiv. 2020.11.16.20232223. Available from: doi:10.1101/2020.11.16.20232223.10.1101/2020.11.16.20232223
- 13. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020;382(18): 1708–1720.10.1056/NEJMoa2002032709281932109013
- 14. Kaur N, Gupta I, Singh H, Karia R, Ashraf A, Habib A, et al. Epidemiological and clinical characteristics of 6635 COVID-19 patients: a pooled analysis. SN Comprehensive Clinical Medicine. 2020;9: 1–5. Available from: doi:10.1007/s42399-020-00393-y.10.1007/s42399-020-00393-y734340732838160
- 15. Aggarwal A, Shrivastava A, Kumar A, Ali A. Clinical and epidemiological features of SARS-CoV-2 patients in SARI ward of a tertiary care centre in New Delhi. Journal of the Association of Physicians of India. 2020;68(7): 19–26.
- 16. Tian S, Liu H, Liao M, Wu Y, Yang C, Cai Y, et al. Analysis of mortality in patients With COVID-19: clinical and laboratory parameters. Open Forum Infectious Diseases. 2020;7(5): ofaa152.10.1093/ofid/ofaa152719755632457924
- 17. Saluja M, Pillai D, Jeliya S, Bauddh N, Chandel R. COVID 19-clinical profile, radiological presentation, prognostic predictors, complications and outcome: A perspective from the Indian sub-continent. Journal of the Association of Physicians of India. 2020;68(7): 13–18.
- 18. Bhatraju PK, Ghassemeih BJ, Nichols M, Kim R, Jierome KR, Nalla AK, et al. Covid-19 in critically Ill patients in the Seattle Region – Case series. The New England Journal of Medicine. 2020;382: 2012–2022.10.1056/NEJMoa2004500714316432227758
- 19. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-cov-2 in Wuhan, China. Allergy. 2020;75(7): 1730–1741.10.1111/all.1423832077115
- 20. Bhandari S, Bhargava A, Sharma S, Keshwani P, Sharma R, Banerjee S. Clinical profile of Covid-19 infected patients admitted in a tertiary care hospital in North India. Journal of the Association of Physicians of India. 2020;68(5): 13–17.
- 21. Shrestha DB, Budhathoki P, Syed N, Rawal E, Raut S, Khadka S. Remdesivir: A potential game changer or just a myth? A systematic review and meta-analysis. Life Sciences. 2020;26: 118663. doi: 10.1016/j.lfs.2020.118663.10.1016/j.lfs.2020.118663758610533121991
- 22. Shrestha DB, Budhathoki P, Khadka S, Shah PB, Pokharel N, Rashmi P. Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis. Virology Journal. 2020;17: 141.10.1186/s12985-020-01412-z751221832972430
- 23. Singh AK, Majumdar S, Singh R, Misra A. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective. Diabetology & Metabolic Syndrome. 2020;14(5): 971–978.10.1016/j.dsx.2020.06.054732071332610262
- 24. Focosi D, Anderson AO, Tang JW, Tuccori M. Convalescent plasma therapy for COVID-19: state of the art. Clinical Microbiology Reviews. 2020;33(4): e00072-20.10.1128/CMR.00072-20743029332792417
- 25. Pan H, Peto R, Karim QA, Alejandria M, Henao-Restrepo Am, Garcia Ch, et al. Repurposed antiviral drugs for COVID-19 – interim WHO SOLIDARITY trial results. WHO Solidarity Trial Consortium. The New England Journal of Medicine. 2021;384:497–511.
- 26. Fu L, Li XY, Fei J, Xiang Y, Xiang HX, Li MD, et al. Myocardial injury at early stage and its association with the risk of death in COVID-19 patients: A Hospital-Based Retrospective Cohort Study. Frontiers in Cardiovascular Medicine. 2020;7: 590688.10.3389/fcvm.2020.590688766163633195480
- 27. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. Global COVID-19 thrombosis collaborative group, endorsed by the ISTH, NATF, ESVM, and the IUA, supported by the ESC working group on pulmonary circulation and right ventricular function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. Journal of the American College of Cardiology. 2020;75(23): 2950–2973. Available from: doi:10.1016/j.jacc.2020.04.031.10.1016/j.jacc.2020.04.031716488132311448
- 28. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369: m1985.10.1136/bmj.m1985724303632444460
- 29. Mohan A, Tiwari P, Bhatnagar S, Patel A, Maurya A, Dar L, et al. Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian Journal of Medical Research. 2020;152(1 & 2): 61–69.10.4103/ijmr.IJMR_1788_20785326032773414
- 30. Xie J, Wu W, Li S, Hu Y, Hu M, Li J, et al. Clinical characteristics and outcomes of critically ill patients with novel corona-virus infectious disease (COVID-19) in China: a retrospective multicenter study. Intensive Care Medicine. 2020;46(10): 1863–1872.10.1007/s00134-020-06211-2743924032816098